A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
ATTR Amyloidosis With CardiomyopathyATTR-CMATTR Amyloidosis Wild TypeMitral RegurgitationTricuspid Regurgitation
Trial Locations (8)

1090

RECRUITING

Department of Internal Medicine II, Medical University of Vienna, Vienna

3450

RECRUITING

University Medical Center Utrecht, Utrecht

8010

RECRUITING

Medical University of Graz, Graz

25100

RECRUITING

Institute of Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia

34100

RECRUITING

Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste

44121

RECRUITING

Cardiologic Centre, Azienda Ospedaliero Universitaria di Ferrara, Ferrara

60596

RECRUITING

Department of Cardiology, University Hospital Frankfurt, Goethe University, Frankfurt am Main

81377

RECRUITING

Medizinische Klinik und Poliklinik I, Klinikum der Universitaet Muenchen, Ludwig-Maximilians-University, Munich

All Listed Sponsors
lead

Medical University of Vienna

OTHER